Dr Reddy

Dr Reddy's saw API revenues slide in FY Q1 2018

Dr Reddy's saw API revenues slide in FY Q1 2018

By Gareth Macdonald

Dr Reddy's says efforts to fix plant problems flagged by US FDA impacted its active pharmaceutical ingredient (API) business in the first quarter of fiscal 2018.